Neonatal jaundice. Neonatal jaundice, unspecified:Physiological jaundice (intense)(prolonged) NOS
Conditions
Interventions
Intervention 1: Administration of probiotics to study group
Pedilact drop from Zist Takhmir Company
10 drop/day. Intervention 2: control group is given only phototherapy.
Treatment - Drugs
Administration of probiotics to study group
Pedilact drop from Zist Takhmir Company
10 drop/day
control group is given only phototherapy.
Sponsors
Babol University of Medical Science
Eligibility
Sex/Gender
All
Age
No minimum to 30 Days
Inclusion criteria
Inclusion criteria: Inclusion criteria : term; healthy; age less than 28 day and more than 1day;weight more than 2500 grams; Exclusion criteria : ABO incompatibility;Rh incompatibility; G6PD deficiency, weight below 2500 gr; history of exchange transfusion in previous sibling; use of drugs such as Phenobarbital during pregnancy; drug and home remedy for jaundice; gestational age less than 37 completed weeks;
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum billirubin level in study group. Timepoint: At admission serum billirubin level. Method of measurement: mg/dl , device: bilitest A from tajhizat sanjesh company.;Serum billirubin level in study group. Timepoint: Second day serum billirubin level. Method of measurement: mg/dl , device: bilitest A from tajhizat sanjesh company.;Serum billirubin level in study group. Timepoint: Third day serum billirubin level. Method of measurement: mg/dl , device: bilitest A from tajhizat sanjesh company.;Serum billirubin level in study group. Timepoint: Forth day serum billirubin level. Method of measurement: mg/dl , device: bilitest A from tajhizat sanjesh company.;Serum billirubin level in contrl group. Timepoint: At admission serum billirubin level. Method of measurement: mg/dl , device: bilitest A from tajhizat sanjesh company.;Serum billirubin level in contrl group. Timepoint: Second day serum billirubin level. Method of measurement: mg/dl , device: bilitest A from tajhizat sanjesh company.;Serum billirubin level in contrl group. Timepoint: Third day serum billirubin. Method of measurement: mg/dl , device: bilitest A from tajhizat sanjesh company.;Serum billirubin level in contrl group. Timepoint: Forth day serum billirubin level. Method of measurement: mg/dl , device: bilitest A from tajhizat sanjesh company. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of admission in control group. Timepoint: At discharge. Method of measurement: Day.;Need of blood exchang transfusion in control group. Timepoint: At discharge. Method of measurement: No.;Need of blood exchang transfusion in control group. Timepoint: At discharge. Method of measurement: Yes.;Need of blood exchang transfusion in study group. Timepoint: At discharge. Method of measurement: No.;Duration of admission in study group. Timepoint: At discharge. Method of measurement: Day.;Need of blood exchang transfusion in study group. Timepoint: At discharge. Method of measurement: Yes. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Abes Ahmadi Jazi
Babol University of Medical Science
Outcome results
None listed